National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indium I 111 bevacizumab
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 bevacizumab binds to vascular endothelial growth factor (VEGF), allowing the detection of VEGF distribution using gamma scintigraphy. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:111-indium labeled bevacizumab



Previous:Incel, incomplete Freund's adjuvant, indibulin, indicine-N-oxide, indinavir sulfate
Next:indium I 111 chimeric monoclonal antibody G250, indium In 111 chimeric monoclonal antibody 806, indium In 111 CHX-A DTPA trastuzumab, indium In 111 ibritumomab tiuxetan, indium In 111 monoclonal antibody BrE-3

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov